Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-T Therapy Complications”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Early research (Phase 1)Active Not RecruitingNCT05239143
What this trial is testing

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerOvarian CancerNon Small Cell Lung Cancer+6 more
Poseida Therapeutics, Inc. 180
Testing effectiveness (Phase 2)Looking for participantsNCT07489534
What this trial is testing

Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction

Who this might be right for
Multiple Myeloma
Daihong Liu 25
Early research (Phase 1)Ended earlyNCT04249947
What this trial is testing

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Who this might be right for
Prostatic Neoplasms, Castration-ResistantNeoplasms by Histologic TypeNeoplasms, Prostate+14 more
Poseida Therapeutics, Inc. 40
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Not applicableLooking for participantsNCT04981119
What this trial is testing

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Who this might be right for
Solid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more
A2 Biotherapeutics Inc. 200
Not applicableLooking for participantsNCT04892433
What this trial is testing

Tissue Study in Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

Who this might be right for
CAR-T Therapy Complications
IRCCS Azienda Ospedaliero-Universitaria di Bologna 150
Very early researchLooking for participantsNCT07507201
What this trial is testing

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Not applicableEnrolling By InvitationNCT06885424
What this trial is testing

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

Who this might be right for
Solid Tumor CancerSolid Tumor, Unspecified, AdultColorectal Carcinoma+12 more
A2 Biotherapeutics Inc. 400
Very early researchNot Yet RecruitingNCT07423572
What this trial is testing

Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)

Who this might be right for
Refractory Idiopathic Membranous Nephropathy
The First Affiliated Hospital of Zhejiang Chinese Medical University 18
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Early research (Phase 1)Looking for participantsNCT06842589
What this trial is testing

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS

Who this might be right for
Multi-Drug Resistant Nephrotic SyndromeCAR-T Cell Therapy
The Children's Hospital of Zhejiang University School of Medicine 18
Early research (Phase 1)Not Yet RecruitingNCT06846424
What this trial is testing

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CarcinomaPeritoneal Carcinoma
Shanghai Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06342960
What this trial is testing

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 2
Very early researchUnknownNCT03814447
What this trial is testing

The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Shanghai 6th People's Hospital 10
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Testing effectiveness (Phase 2)Active Not RecruitingNCT05938725
What this trial is testing

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06935474
What this trial is testing

C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease

Who this might be right for
Lupus Nephritis (LN)
AbelZeta Inc. 24
Load More Results